Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,358,000 | 8,534,000 | 3,963,000 | 2,749,000 | 4,523,000 |
| Depreciation Amortization | 3,214,000 | 2,379,000 | 1,620,000 | 892,000 | 3,486,000 |
| Income taxes - deferred | 187,000 | 28,000 | 29,000 | 18,000 | -566,000 |
| Accounts receivable | -2,033,000 | N/A | N/A | N/A | -1,002,000 |
| Accounts payable and accrued liabilities | 405,000 | N/A | N/A | N/A | 684,000 |
| Other Working Capital | -3,839,000 | -3,794,000 | -3,655,000 | -2,192,000 | -4,601,000 |
| Other Operating Activity | 2,830,000 | 880,000 | 1,273,000 | -227,000 | 5,093,000 |
| Operating Cash Flow | $13,122,000 | $8,027,000 | $3,230,000 | $1,240,000 | $7,617,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,025,000 | 496,000 | 385,000 | 385,000 | 2,717,000 |
| PPE Investments | -4,448,000 | -3,240,000 | -2,068,000 | -1,082,000 | -4,429,000 |
| Net Acquisitions | -12,907,000 | -1,643,000 | -1,644,000 | N/A | -6,606,000 |
| Other Investing Activity | -91,000 | 15,000 | 16,000 | 11,000 | -875,000 |
| Investing Cash Flow | $-16,421,000 | $-4,372,000 | $-3,311,000 | $-686,000 | $-9,193,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -3,986,000 | -3,983,000 | -3,983,000 | 788,000 | 2,549,000 |
| Debt Issued | 7,936,000 | N/A | N/A | N/A | 4,419,000 |
| Debt Repayment | -2,319,000 | -1,153,000 | -1,153,000 | -1,153,000 | -1,957,000 |
| Common Stock Issued | 202,000 | 68,000 | 51,000 | 9,000 | 89,000 |
| Common Stock Repurchased | -840,000 | -822,000 | -239,000 | N/A | -1,281,000 |
| Dividend Paid | -6,610,000 | -4,967,000 | -3,318,000 | -1,645,000 | -6,215,000 |
| Other Financing Activity | 8,714,000 | 8,747,000 | 8,806,000 | -97,000 | -436,000 |
| Financing Cash Flow | $3,097,000 | $-2,110,000 | $164,000 | $-2,098,000 | $-2,832,000 |
| Exchange Rate Effect | -133,000 | -65,000 | -19,000 | -97,000 | 253,000 |
| Beginning Cash Position | 8,153,000 | 8,153,000 | 8,153,000 | 8,165,000 | 9,934,000 |
| End Cash Position | 8,167,000 | 10,046,000 | 8,630,000 | 7,023,000 | 8,165,000 |
| Net Cash Flow | $14,000 | $1,893,000 | $477,000 | $-1,142,000 | $-1,769,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,122,000 | 8,027,000 | 3,230,000 | 1,240,000 | 7,617,000 |
| Capital Expenditure | -4,448,000 | -3,240,000 | -2,068,000 | -1,082,000 | -4,429,000 |
| Free Cash Flow | 8,674,000 | 4,787,000 | 1,162,000 | 158,000 | 3,188,000 |